Reza Yadegarazari1,2, Taghi Hassanzadeh1, Amir Majlesi3, Amir Keshvari4, Alireza Monsef Esfahani5, Amirsasan Tootoonchi1, Nooshin Shabab1,2, Massoud Saidijam1,2. 1. Research Center for Molecular Medicine, Hamadan University of Medical Sciences, Hamadan, Iran. 2. Dept. of Genetics and Molecular Medicine, Hamadan University of Medical Sciences, Hamadan, Iran. 3. Dept. of Gastrointestinal Disease, Beheshti Hospital of Hamadan University of Medical Sciences, Hamadan, Iran. 4. Dept. of General Surgery, Imam Khomeini Hospital of Tehran University of Medical Sciences, Tehran, Iran. 5. Dept. of Pathology, Hamadan University of Medical Sciences, Hamadan, Iran.
Abstract
BACKGROUND: Efficient screening for detection of colorectal cancer (CRC) at earlier stages reduces its mortality. The purpose of this study was to investigate expression of carcinoembryonic antigen (CEA) and human telomerase reverse transcriptase (hTERT) mRNA in peripheral blood of CRC patients and to present strategies for early detection screen test. METHODS: Twenty seven patients in non-metastatic stage and 27 healthy individuals were studied. Expression of CEA, hTERT mRNA and 18srRNA (18s subunit of ribosomal RNA, as reference gene) were determined based on real-time RT-PCR on 3 µg of total RNA from blood in 3 separate vials (1 µg per vial). RESULTS: Positive expression rate of CEA mRNA (78%) and hTERT mRNA (81%) were higher in patient group (P<0.001). These rates were meaningfully higher than the results of individual vials containing only 1 µg of total RNA. Difference between Ct values of markers with 18srRNA ΔCt) was higher in healthy group than patient one. Therefore, a ΔCt cut-off value was determined for distinguishing between true- and false-positive results. Concurrent expression of both markers was found in 67% of the patients, which was higher than healthy cases (11%). Combination of concurrent marker expression with cut-off point strategy increased specificity to 100%. CONCLUSION: These results showed that concurrent evaluation of marker expression and performing the test on 3 µg of samples in 3 separate vials may increase specificity and sensitivity of real-time RT-PCR for early detection of non-metastatic CRC. However, more investigations with larger numbers of samples are needed to verify these results.
BACKGROUND: Efficient screening for detection of colorectal cancer (CRC) at earlier stages reduces its mortality. The purpose of this study was to investigate expression of carcinoembryonic antigen (CEA) and humantelomerase reverse transcriptase (hTERT) mRNA in peripheral blood of CRC patients and to present strategies for early detection screen test. METHODS: Twenty seven patients in non-metastatic stage and 27 healthy individuals were studied. Expression of CEA, hTERT mRNA and 18srRNA (18s subunit of ribosomal RNA, as reference gene) were determined based on real-time RT-PCR on 3 µg of total RNA from blood in 3 separate vials (1 µg per vial). RESULTS: Positive expression rate of CEA mRNA (78%) and hTERT mRNA (81%) were higher in patient group (P<0.001). These rates were meaningfully higher than the results of individual vials containing only 1 µg of total RNA. Difference between Ct values of markers with 18srRNA ΔCt) was higher in healthy group than patient one. Therefore, a ΔCt cut-off value was determined for distinguishing between true- and false-positive results. Concurrent expression of both markers was found in 67% of the patients, which was higher than healthy cases (11%). Combination of concurrent marker expression with cut-off point strategy increased specificity to 100%. CONCLUSION: These results showed that concurrent evaluation of marker expression and performing the test on 3 µg of samples in 3 separate vials may increase specificity and sensitivity of real-time RT-PCR for early detection of non-metastatic CRC. However, more investigations with larger numbers of samples are needed to verify these results.
Entities:
Keywords:
Carcinoembryonic antigen; Biomarker; Colorectal cancer
Authors: Ulrich Guller; Paul Zajac; Annelies Schnider; Beatrix Bösch; Stefan Vorburger; Markus Zuber; Giulio Cesare Spagnoli; Daniel Oertli; Robert Maurer; Urs Metzger; Felix Harder; Michael Heberer; Walter Richard Marti Journal: Ann Surg Date: 2002-12 Impact factor: 12.969
Authors: R Q Wharton; S K Jonas; C Glover; Z A Khan; A Klokouzas; H Quinn; M Henry; T G Allen-Mersh Journal: Clin Cancer Res Date: 1999-12 Impact factor: 12.531
Authors: H Niiyama; K Mizumoto; N Sato; E Nagai; R Mibu; T Fukui; M Kinoshita; M Tanaka Journal: Am J Gastroenterol Date: 2001-06 Impact factor: 10.864
Authors: S Sadahiro; T Suzuki; N Tokunaga; S Yurimoto; S Yasuda; T Tajima; H Makuuchi; C Murayama; K Matsuda Journal: Cancer Date: 2001-09-01 Impact factor: 6.860
Authors: Simone Mocellin; Carlo R Rossi; Pierluigi Pilati; Donato Nitti; Francesco M Marincola Journal: Trends Mol Med Date: 2003-05 Impact factor: 11.951